PMC:7278327 / 5174-5949
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T31 | 128-131 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
T32 | 357-362 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T33 | 363-368 | Body_part | denotes | brain | http://purl.org/sig/ont/fma/fma50801 |
T34 | 448-451 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
T35 | 639-647 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T36 | 691-694 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T10 | 357-376 | Body_part | denotes | blood-brain barrier | http://purl.obolibrary.org/obo/UBERON_0000120 |
T11 | 357-362 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T12 | 363-368 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
183 | 53-58 | Gene | denotes | nAChR | Gene:1137 |
184 | 659-689 | Species | denotes | human immunodeficiency virus 1 | Tax:11676 |
185 | 691-696 | Species | denotes | HIV-1 | Tax:11676 |
186 | 707-715 | Species | denotes | MERS-CoV | Tax:1335626 |
187 | 733-750 | Species | denotes | hepatitis C virus | Tax:11103 |
188 | 95-99 | Species | denotes | RABV | Tax:11292 |
189 | 307-311 | Species | denotes | RABV | Tax:11292 |
190 | 396-400 | Species | denotes | RABV | Tax:11292 |
191 | 517-521 | Species | denotes | RABV | Tax:11292 |
192 | 597-601 | Species | denotes | RABV | Tax:11292 |
193 | 752-755 | Species | denotes | HCV | Tax:11103 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T54 | 665-681 | Disease | denotes | immunodeficiency | http://purl.obolibrary.org/obo/MONDO_0021094 |
T55 | 733-744 | Disease | denotes | hepatitis C | http://purl.obolibrary.org/obo/MONDO_0005231 |
T56 | 733-742 | Disease | denotes | hepatitis | http://purl.obolibrary.org/obo/MONDO_0002251 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T63 | 70-71 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T64 | 128-131 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
T65 | 128-131 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
T66 | 357-362 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T67 | 357-362 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T68 | 363-368 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
T69 | 363-368 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | brain |
T70 | 448-451 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
T71 | 448-451 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
T72 | 522-525 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T73 | 659-664 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T74 | 682-687 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T75 | 745-750 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T12 | 435-440 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T13 | 639-647 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 53-58 | http://purl.obolibrary.org/obo/GO_0022848 | denotes | nAChR |
T21 | 132-141 | http://purl.obolibrary.org/obo/GO_0006810 | denotes | transport |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T26 | 0-257 | Sentence | denotes | Several empirical studies have demonstrated that the nAChR represents a major receptor for the RABV that mechanistically drives CNS transport of infective viral particles, leading to classic neurological sequelae associated with disease progression [15–17]. |
T27 | 258-476 | Sentence | denotes | Due to the efficient neuroinvasive properties of RABV [18,19], including the ability to bypass the blood-brain barrier, studies have used RABV-based vectors for the delivery of drugs to the CNS, with some success [20]. |
T28 | 477-775 | Sentence | denotes | Furthermore, genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV particles expressing chimeric capsid proteins containing human immunodeficiency virus 1 (HIV-1) [21,22], MERS-CoV, Ebolavirus, and hepatitis C virus (HCV) sequences [23–25]. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T8 | 665-681 | Phenotype | denotes | immunodeficiency | http://purl.obolibrary.org/obo/HP_0002721 |
T9 | 733-742 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32463026-3448605-69142632 | 250-252 | 3448605 | denotes | 15 |
32463026-8887475-69142632 | 250-252 | 8887475 | denotes | 15 |
32463026-30772332-69142632 | 250-252 | 30772332 | denotes | 15 |
32463026-19946287-69142633 | 313-315 | 19946287 | denotes | 18 |
32463026-23602163-69142634 | 316-318 | 23602163 | denotes | 19 |
32463026-27581650-69142635 | 472-474 | 27581650 | denotes | 20 |
32463026-10706640-69142636 | 699-701 | 10706640 | denotes | 21 |
32463026-14610200-69142637 | 702-704 | 14610200 | denotes | 22 |
32463026-26063224-69142638 | 768-770 | 26063224 | denotes | 23 |
32463026-11878905-69142638 | 768-770 | 11878905 | denotes | 23 |